Kayyem Jon Faiz
SEC insider (Form 3/4/5 filer). CIK 0001366268. Director at Inhibrx Biosciences, Inc. (INBX) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in LA JOLLA, CA.
Companies Kayyem Jon Faiz has filed insider reports for
- Inhibrx Biosciences, Inc. (INBX): Director
- BIODESIX INC (BDSX): Director
Kayyem Jon Faiz
CIK: 0001366268
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 23, 2026INBX
Inhibrx Biosciences, Inc.
PurchaseIndirect5K shares at avg. $100.00$500K - Sep 16, 2026INBX
Inhibrx Biosciences, Inc.
PurchaseIndirect5K shares at avg. $100.00$500K - Sep 8, 2026INBX
Inhibrx Biosciences, Inc.
PurchaseIndirect5K shares at avg. $113.52$568K - Jun 3, 2026INBX
Inhibrx Biosciences, Inc.
AwardDirectStock Option (right to buy)
10K shares- - Jan 2, 2026BDSX
BIODESIX INC
AwardDirectRestricted Stock Units
5.4K shares- - Jan 2, 2026BDSX
BIODESIX INC
AwardDirectStock Options (Right to Buy)
6.4K shares- - May 28, 2025INBX
Inhibrx Biosciences, Inc.
AwardDirectStock Option (right to buy)
15K shares- - May 20, 2025BDSX
BIODESIX INC
AwardDirectStock Options (Right to Buy)
42K shares- - May 20, 2025BDSX
BIODESIX INC
AwardDirectRestricted Stock Units
68.6K shares- - Mar 27, 2025INBX
Inhibrx Biosciences, Inc.
GiftIndirect90K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  INBX Inhibrx Biosciences, Inc. | Purchase | 5,000 | $100.00 | $500,000 | Indirect |
| Sep 16, 2026 | INBX Inhibrx Biosciences, Inc. | Purchase | 5,000 | $100.00 | $500,000 | Indirect |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | Purchase | 5,000 | $113.52 | $567,580 | Indirect |
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| Jan 2, 2026 |  BDSX BIODESIX INC | Award Restricted Stock Units | 5,443 | - | - | Direct |
| Jan 2, 2026 | BDSX BIODESIX INC | Award Stock Options (Right to Buy) | 6,354 | - | - | Direct |
| May 28, 2025 | INBX Inhibrx Biosciences, Inc. | Award Stock Option (right to buy) | 15,000 | - | - | Direct |
| May 20, 2025 | BDSX BIODESIX INC | Award Stock Options (Right to Buy) | 42,010 | - | - | Direct |
| May 20, 2025 | BDSX BIODESIX INC | Award Restricted Stock Units | 68,621 | - | - | Direct |
| Mar 27, 2025 | INBX Inhibrx Biosciences, Inc. | Gift | 90,000 | - | - | Indirect |
1-10 of 18 transactions